SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001650664-23-000038
Filing Date
2023-12-13
Accepted
2023-12-13 09:02:25
Documents
15
Period of Report
2023-12-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20231212.htm   iXBRL 8-K 32657
2 EX-99.1 ex991-pressreleaseddated.htm EX-99.1 5814
6 GRAPHIC ex991-pressreleaseddated001.jpg GRAPHIC 273931
7 ex991-pressreleaseddated002.jpg GRAPHIC 111176
  Complete submission text file 0001650664-23-000038.txt   698086

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT edit-20231212.xsd EX-101.SCH 1922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT edit-20231212_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT edit-20231212_pre.xml EX-101.PRE 12522
9 EXTRACTED XBRL INSTANCE DOCUMENT edit-20231212_htm.xml XML 2714
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 231483073
SIC: 2836 Biological Products, (No Diagnostic Substances)